Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice.
Sign Up to like & getrecommendations! Published in 2018 at "Infectious disease clinics of North America"
DOI: 10.1016/j.idc.2018.02.001
Abstract: Injection drug use is the most common transmission route for hepatitis C. High rates of infection are observed among individuals on opioid agonist therapy. Although people who inject drugs carry the highest burden, few have… read more here.
Keywords: hepatitis; treatment; opioid agonist; agonist therapy ... See more keywords
Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neurosciences in Rural Practice"
DOI: 10.1055/s-0041-1736509
Abstract: Objectives Illicit opioid use is a major concern across the globe due to its adverse health consequences. Pharmacological intervention is regarded as the cornerstone of management of opioid dependence and the Opioid Agonist Treatment (OAT)… read more here.
Keywords: north india; oat clinic; agonist treatment; use ... See more keywords
Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?
Sign Up to like & getrecommendations! Published in 2019 at "Substance Abuse"
DOI: 10.1080/08897077.2019.1640831
Abstract: Abstract Background: Despite substantial benefits associated with opioid agonist treatment (OAT) with buprenorphine and methadone for opioid use disorder (OUD), only a small proportion of patients with OUD initiate OAT. There is a lack of… read more here.
Keywords: use; oat; treatment; buprenorphine ... See more keywords
Assessing cardiac safety among clients receiving methadone as part of opioid agonist maintenance therapy (OAMT) in Durban, South Africa
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Addictive Diseases"
DOI: 10.1080/10550887.2022.2063640
Abstract: Abstract Background: Methadone is a recommended medication for opioid agonist maintenance therapy (OAMT). However, methadone can have cardiac side effects. There is limited South African cardiac safety data on methadone. Objective: To describe baseline and… read more here.
Keywords: cardiac safety; symptomatology; ecg; methadone ... See more keywords
Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Addiction Medicine"
DOI: 10.1097/adm.0000000000000369
Abstract: Objective: Few studies examine how payers address the need for improved access to pharmacotherapy for opioid use disorders and the influence of environmental variables on access to opioid agonist and antagonist medications. Method: The 52… read more here.
Keywords: addiction; policy; treatment; agonist antagonist ... See more keywords
HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case Series
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Addiction Medicine"
DOI: 10.1097/adm.0000000000000609
Abstract: Objectives: Injectable opioid agonist therapy (iOAT) has previously been demonstrated to be an effective treatment option for individuals with a severe opioid use disorder (OUD) who have been unsuccessful on first line therapy (eg, buprenorphine/naloxone… read more here.
Keywords: therapy; initiation; hiv; treatment ... See more keywords
Reduction in mortality risk with opioid agonist therapy: a systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2019 at "Acta Psychiatrica Scandinavica"
DOI: 10.1111/acps.13088
Abstract: Opioid agonist therapies are effective medications that can greatly improve the quality of life of individuals with opioid use disorder. However, there is significant uncertainty about the risks of cause‐specific mortality in and out of… read more here.
Keywords: reduction mortality; risk opioid; mortality risk; agonist therapy ... See more keywords
One size does not fit all—evolution of opioid agonist treatments in a naturalistic setting over 23 years
Sign Up to like & getrecommendations! Published in 2019 at "Addiction"
DOI: 10.1111/add.14442
Abstract: BACKGROUND AND AIMS Opioid agonist treatment (OAT) is currently the most effective treatment for people with opioid dependence. In most countries, however, access to the whole range of effective medications is restricted. This study aims… read more here.
Keywords: one size; size fit; patient characteristics; treatment ... See more keywords
Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: Dynamic modeling analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Addiction"
DOI: 10.1111/add.14797
Abstract: BACKGROUND AND AIMS Although opioid agonist treatment (OAT) for opioid use disorder (OUD) is cost-effective in settings where the HIV epidemic is concentrated among people who inject drugs, OAT coverage in Ukraine remains far below… read more here.
Keywords: capacity; oat; treatment; agonist treatment ... See more keywords
Global opioid agonist treatment: A review of clinical practices by country.
Sign Up to like & getrecommendations! Published in 2020 at "Addiction"
DOI: 10.1111/add.15087
Abstract: AIMS We assessed how opioid agonist treatment (OAT) for opioid use disorder (OUD), specifically methadone and buprenorphine, including buprenorphine-naloxone, is delivered in routine clinical practice, with a focus on factors that affect access to and… read more here.
Keywords: buprenorphine; agonist treatment; opioid agonist; global opioid ... See more keywords
Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
Sign Up to like & getrecommendations! Published in 2020 at "Addiction"
DOI: 10.1111/add.15168
Abstract: AIMS To estimate incidence and predictors of opioid agonist therapy (OAT) discontinuation in a national cohort of people who inject drugs (PWID). Design and Setting Annually repeated cross-sectional sero-surveillance among PWID attending ~50 needle syringe… read more here.
Keywords: oat; inject drugs; discontinuation; buprenorphine ... See more keywords